Overview

Receptor Occupancy of LB-102 Using Positron Emission Tomography (PET) in Healthy Volunteers

Status:
Active, not recruiting
Trial end date:
2021-11-15
Target enrollment:
Participant gender:
Summary
This is an open label study in 4 cohort of 4 healthy volunteers each designed to evaluate the dopamine receptor occupancy of LB-102 at various doses and timepoints.
Phase:
Phase 1
Details
Lead Sponsor:
LB Pharmaceuticals Inc.
Collaborator:
Washington University School of Medicine